Latest Regulatory Approval News

Page 8 of 346
Lakes Blue Energy has secured approvals for the next Wombat-5 testing phase, with work expected to begin in mid-November. The milestone comes as the company reports $4.16 million in cash but only 1.68 quarters of funding at the September quarter’s spending rate.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Bayan Mining and Minerals completed maiden drilling at Desert Star and reported encouraging early yttrium processing results, but ended September with A$865,000 in cash and only 1.44 quarters of funding at the reported spending rate. The company says future capital raisings are expected to support ongoing exploration and development.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Jade Gas has progressed a proposed consortium-backed development for its Mongolian coal bed methane project, with 100% of Phase 1 capital expenditure potentially funded by a Chinese-led group. The opportunity is substantial, but the agreement remains non-binding and binding documents are now targeted for November.
Victor Sage
Victor Sage
30 Oct 2026
Alterity Therapeutics says it has begun operational preparations for a Phase 3 ATH434 trial after FDA minutes confirmed the proposed design and registrational pathway in Multiple System Atrophy. The company ended September with A$41.3 million in cash, while a new US patent extends protection for ATH434 to 2045.
Ada Torres
Ada Torres
30 Oct 2026
El Dorado Goldfields has begun testing a 180km² Guyana land package after securing an option to acquire a 90% interest in the Oko North and Oko South projects. Early rock-chip assays reached 2.32 g/t gold, but the greenfields projects remain undrilled and have no defined resources or reserves.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Cokal has resumed mining and hauling at its 60%-owned Bumi Barito Mineral project after delayed Indonesian regulatory approval, but exceptionally low Barito River levels have pushed the next shipment to a tentative mid-November date. The company also bought three years of extra time on BBM's US$20 million repayment, while quarter-end cash stood at just US$193,000.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Pinnacle Minerals is seeking shareholder approval for a securities-funded acquisition of five early-stage tungsten projects in Utah, alongside a proposed A$1.3 million placement. The transaction would bring new management, substantial exploration commitments and a sharply larger pool of performance securities.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Wide Open Agriculture has completed the major physical steps in exiting its German manufacturing facility and is now testing four prospective Asian production partners. The transition could lower fixed costs, but commercial supply still depends on technical trials, partner selection and a definitive agreement.
Victor Sage
Victor Sage
30 Oct 2026
Burley Minerals has confirmed shallow Channel Iron Deposit mineralisation across its Cane Bore North and Step-Out Targets, with assays reaching 52.7% iron. The exploration success comes alongside $725,000 in cash and an estimated 2.04 quarters of funding at current outgoings.
Maxwell Dee
Maxwell Dee
30 Oct 2026
OncoSil Medical enters FY27 with FDA approval for its cancer device, rising quarterly revenue and fresh institutional funding, but its U.S. opportunity still depends on reimbursement and a tightly controlled initial rollout. Cash rose to A$8.7 million after the capital raise, while operating cash use remained substantial.
Victor Sage
Victor Sage
30 Oct 2026
Bio-Gene Technology has moved closer to two commercialisation milestones, with Qcide product work progressing in Japan and a first Flavocide regulatory submission targeted for Q2 2027. The company ended September with A$2.103 million in cash, equivalent to an estimated 2.18 quarters of funding at the quarter’s operating cash rate.
Victor Sage
Victor Sage
30 Oct 2026
Algorae Pharmaceuticals has moved closer to its first expected NSW Health supply orders while reporting stronger preclinical results from its AOS2 drug-discovery platform. The company ended September with $3.15 million in cash and a further $3 million undrawn facility, but its commercial contract carries no minimum volume commitment.
Victor Sage
Victor Sage
30 Oct 2026

Browse the archive

Full archive